Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure‐Response Analyses Underutilized?

por Jones, Aksana K., Salem, Ahmed Hamed, Freise, Kevin J.
Publicado 2019

Semimechanistic Modeling to Guide Venetoclax Coadministration with Ritonavir and Digoxin

por Alhadab, Ali A., Salem, Ahmed Hamed, Freise, Kevin J.
Publicado 2020

Model-based meta-analysis of progression-free survival in non-Hodgkin lymphoma patients

por Li, Mengyao, Dave, Nimita, Salem, Ahmed Hamed, Freise, Kevin J.
Publicado 2017

Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia Trials

por Agarwal, Suresh K., Mangal, Naveen, Menon, Rajeev M., Freise, Kevin J., Salem, Ahmed Hamed
Publicado 2017

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

por D'Souza, Anita, Shah, Nina, Rodriguez, Cesar, Voorhees, Peter M., Weisel, Katja, Bueno, Orlando F., Pothacamury, Rajvineeth K., Freise, Kevin J., Yue, Susan, Ross, Jeremy A., Polepally, Akshanth R., Talati, Chetasi, Lee, Shane, Jin, Ziyi, Buelow, Ben, Vij, Ravi, Kumar, Shaji
Publicado 2022